DOSSIER · 13F-HR · Q2 2026

B Group, Inc.

$213M in tracked AUM across 19 positions as of Q2 2026.

BG
CIK 0002043476 · last filed Jun 30, 2026
Total AUM
$213M
as of Q2 2026
Holdings
19
positions
Whale Score
66
66
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Portfolio Overview

B Group, Inc. has undergone a significant transformation in the quarter ending September 30, 2025. The firm executed a substantial reduction in portfolio size, with total assets under management (AUM) plummeting by 50.9%, dropping from $129.94 million to $63.85 million. This drastic capital reduction was accompanied by a shift in concentration; the firm exited eight positions while consolidating capital into a tighter list of 12 holdings. The portfolio is currently highly...

Key Holdings

The portfolio is dominated by two distinct "core" positions: NVIDIA Corporation (NVDA) and Zai Lab Ltd (ZLAB), which represent 21.92% and 21.23% of the portfolio, respectively.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
46090E953
INVESCO QQQ TR
$37M50K17.3%
02
ADMA
ADMA BIOLOGICS INC
$27M3.3M12.8%
03
PALI
PALISADE BIO INC
$24M11.4M11.2%
04
NRXP
NRX PHARMACEUTICALS INC
$17M4.1M7.9%
05
SNSE
FAETH THERAPEUTICS INC
$15M610K7.2%
06
TSHA
TAYSHA GENE THERAPIES INC
$12M1.8M5.8%
07
PRAX
PRAXIS PRECISION MEDICINES I
$11M33K5.2%
08
CLLS
CELLECTIS S A
$10M3.3M4.6%
09
ZLAB
ZAI LAB LTD
$9M451K4.0%
10
GPCR
STRUCTURE THERAPEUTICS INC
$8M140K3.5%

Filing history

2026Q2Jun 30
$213M 57.9%
19 positionsView →
2026Q1Mar 31
$135M 0.4%
20 positionsView →
2025Q4Dec 31
$135M 112.1%
16 positionsView →
2025Q3Sep 30
$64M 50.9%
12 positionsView →
2025Q2Jun 30
$130M 11.3%
17 positionsLocked
2025Q1Mar 31
$117M 28.6%
19 positionsLocked
2024Q4Dec 31
$164M
18 positionsLocked